T2 Biosystems brings in $10.8M for diagnostics

T2 Biosystems, a company working to develop new diagnostic methods, received $10.8 million in second-round financing from new investors In-Q-Tel (which also helps fund the CIA, incidentally) and Partners Healthcare, and existing investors Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners.

The Cambridge, Mass.-based company plans to use the new money to develop a beta version of a device combining MRI properties and nanotechnology and to run it through a series of tests over the next 18 months, reports VentureWire. It raised $5.5 million in a first round of funding in 2006, and currently has 20 employees.

Next Story: CeNeRx takes $15M to fight depression
Previous Story: Pandora fires 20, despite rising listenership and growing ad sales